BDX
Price
$184.60
Change
+$4.01 (+2.22%)
Updated
Sep 26 closing price
Capitalization
52.91B
39 days until earnings call
SRDX
Price
$29.94
Change
-$0.88 (-2.86%)
Updated
Sep 26 closing price
Capitalization
428.07M
38 days until earnings call
Interact to see
Advertisement

BDX vs SRDX

Header iconBDX vs SRDX Comparison
Open Charts BDX vs SRDXBanner chart's image
Becton Dickinson and
Price$184.60
Change+$4.01 (+2.22%)
Volume$1.27M
Capitalization52.91B
Surmodics
Price$29.94
Change-$0.88 (-2.86%)
Volume$282.36K
Capitalization428.07M
BDX vs SRDX Comparison Chart in %
Loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDX vs. SRDX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and SRDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (BDX: $184.60 vs. SRDX: $29.94)
Brand notoriety: BDX and SRDX are both not notable
BDX represents the Pharmaceuticals: Other, while SRDX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BDX: 60% vs. SRDX: 113%
Market capitalization -- BDX: $52.91B vs. SRDX: $428.07M
BDX [@Pharmaceuticals: Other] is valued at $52.91B. SRDX’s [@Medical/Nursing Services] market capitalization is $428.07M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.44B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.82B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.42B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, BDX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 4 TA indicator(s) are bullish while SRDX’s TA Score has 5 bullish TA indicator(s).

  • BDX’s TA Score: 4 bullish, 5 bearish.
  • SRDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BDX is a better buy in the short-term than SRDX.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а -1.30% price change this week, while SRDX (@Medical/Nursing Services) price change was -7.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.

Reported Earning Dates

BDX is expected to report earnings on Nov 06, 2025.

SRDX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.97% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($52.9B) has a higher market cap than SRDX($428M). SRDX has higher P/E ratio than BDX: SRDX (43.13) vs BDX (33.75). BDX YTD gains are higher at: -17.321 vs. SRDX (-24.394). SRDX has less debt than BDX: SRDX (32.6M) vs BDX (19.3B).
BDXSRDXBDX / SRDX
Capitalization52.9B428M12,360%
EBITDAN/A-2.74M-
Gain YTD-17.321-24.39471%
P/E Ratio33.7543.1378%
RevenueN/A121M-
Total CashN/A32.7M-
Total Debt19.3B32.6M59,202%
FUNDAMENTALS RATINGS
BDX vs SRDX: Fundamental Ratings
BDX
SRDX
OUTLOOK RATING
1..100
7858
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8295
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
8393
SEASONALITY SCORE
1..100
5039

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (21) in the Medical Specialties industry is significantly better than the same rating for SRDX (94). This means that BDX’s stock grew significantly faster than SRDX’s over the last 12 months.

BDX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's SMR Rating (82) in the Medical Specialties industry is in the same range as SRDX (95). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's Price Growth Rating (62) in the Medical Specialties industry is in the same range as SRDX (63). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's P/E Growth Rating (83) in the Medical Specialties industry is in the same range as SRDX (93). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXSRDX
RSI
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
63%
Momentum
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
45%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
40%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
36%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 11 days ago
45%
Bullish Trend 10 days ago
67%
Declines
ODDS (%)
Bearish Trend 4 days ago
36%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SLV41.860.83
+2.02%
iShares Silver Trust
PLDR35.640.15
+0.44%
Putnam Sustainable Leaders ETF
PCGG12.240.03
+0.21%
Polen Capital Global Growth ETF
ZTRE51.27-0.05
-0.10%
F/M 3-Yr Invmt Grd Corp Bd ETF
AAPW41.52-0.38
-0.91%
Roundhill AAPL WeeklyPay ETF

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with TMO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
+2.22%
TMO - BDX
49%
Loosely correlated
+1.09%
CNMD - BDX
48%
Loosely correlated
+0.02%
TFX - BDX
48%
Loosely correlated
+2.56%
STE - BDX
45%
Loosely correlated
+2.00%
RVTY - BDX
45%
Loosely correlated
+1.23%
More

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-2.86%
PXMBF - SRDX
41%
Loosely correlated
N/A
BDX - SRDX
32%
Poorly correlated
+2.22%
BLCO - SRDX
30%
Poorly correlated
+0.90%
TFX - SRDX
29%
Poorly correlated
+2.56%
UFPT - SRDX
28%
Poorly correlated
+1.84%
More